Jim DuCharme vs Ravi Ika | Comparably
VS
Profile Image
Prime Therapeutics Claimed Company
EMPLOYEE
PARTICIPANTS
53
TOTAL
RATINGS
422
RxAdvance Claimed Company
EMPLOYEE
PARTICIPANTS
9
TOTAL
RATINGS
126

Jim DuCharme vs Ravi Ika

Jim DuCharme Prime Therapeutics' CEO
Jim DuCharme
Prime Therapeutics
Top 35%
Top 35% of Similar Size Companies on Comparably
B
70/100
VS
Ravi Ika RxAdvance's CEO
Ravi Ika
RxAdvance
Bottom 20%
Bottom 20% of Similar Size Companies on Comparably
D
59/100

Prime Therapeutics vs RxAdvance CEO Comparison Summary

Employees at Prime Therapeutics rank Jim DuCharme in the Top 35% of CEOs in Minneapolis. Comparatively, employees at RxAdvance rank Ravi Ika in the Bottom 20% of CEOs in Boston. Employees rate their CEO differently based on the frequency of interaction, ability to affect company culture, and drive measurable results.

Gender Score

Jim DuCharme Prime Therapeutics' CEO
Jim DuCharme
Prime Therapeutics
Top 25%
Top 25% of Similar Size Companies on Comparably
B
Gender

Women at Prime Therapeutics rated their CEO a B

Ravi Ika RxAdvance's CEO
Ravi Ika
RxAdvance
N/A
Gender

Not Enough Data

Diversity Score

Jim DuCharme Prime Therapeutics' CEO
Jim DuCharme
Prime Therapeutics
N/A
Diversity

Not Enough Data

Ravi Ika RxAdvance's CEO
Ravi Ika
RxAdvance
N/A
Diversity

Not Enough Data

Who Ranks the CEO highest?

Jim DuCharme Prime Therapeutics' CEO
Jim DuCharme
Prime Therapeutics
Department - N/A
73/100Ethnicity - Caucasian
Tenure - N/A
Education - N/A
60/100Experience - 3 to 6 Years
Ravi Ika RxAdvance's CEO
Ravi Ika
RxAdvance
N/A

Not Enough Data